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Lipid peroxidation is essential for α-synuclein-induced cell death
Abstract

Parkinson's disease is the second most common neurodegenerative disease and its pathogenesis is closely
associated with oxidative stress. Deposition of aggregated α-synuclein (α-Syn) occurs in familial and sporadic
forms of Parkinson's disease. Here, we studied the effect of oligomeric α-Syn on one of the major markers of
oxidative stress, lipid peroxidation, in primary co-cultures of neurons and astrocytes. We found that
oligomeric but not monomeric α-Syn significantly increases the rate of production of reactive oxygen species,
subsequently inducing lipid peroxidation in both neurons and astrocytes. Pre-incubation of cells with isotopereinforced polyunsaturated fatty acids (D-PUFAs) completely prevented the effect of oligomeric α-Syn on
lipid peroxidation. Inhibition of lipid peroxidation with D-PUFAs further protected cells from cell death
induced by oligomeric α-Syn. Thus, lipid peroxidation induced by misfolding of α-Syn may play an important
role in the cellular mechanism of neuronal cell loss in Parkinson's disease. We have found that aggregated αsynuclein-induced production of reactive oxygen species (ROS) that subsequently stimulates lipid
peroxidation and cell death in neurons and astrocytes. Specific inhibition of lipid peroxidation by incubation
with reinforced polyunsaturated fatty acids (D-PUFAs) completely prevented the effect of α-synuclein on
lipid peroxidation and cell death.
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Abstract
Parkinson’s disease is the second most common neurodegenerative disease and its pathogenesis is closely associated
with oxidative stress. Deposition of aggregated a-synuclein
(a-Syn) occurs in familial and sporadic forms of Parkinson’s
disease. Here, we studied the effect of oligomeric a-Syn on
one of the major markers of oxidative stress, lipid peroxidation,
in primary co-cultures of neurons and astrocytes. We found
that oligomeric but not monomeric a-Syn signiﬁcantly
increases the rate of production of reactive oxygen species,
subsequently inducing lipid peroxidation in both neurons and

astrocytes. Pre-incubation of cells with isotope-reinforced
polyunsaturated fatty acids (D-PUFAs) completely prevented
the effect of oligomeric a-Syn on lipid peroxidation. Inhibition of
lipid peroxidation with D-PUFAs further protected cells from
cell death induced by oligomeric a-Syn. Thus, lipid peroxidation induced by misfolding of a-Syn may play an important role
in the cellular mechanism of neuronal cell loss in Parkinson’s
disease.
Keywords: deuterated PUFA, lipid peroxidation, oxidative
stress, a-synuclein.
J. Neurochem. (2015) 133, 582–589

Although Parkinson’s disease is a complex multifactorial
disorder, one key causal factor remains the misfolding and
aggregation of the protein a-Syn. The major histopathological hallmarks of Parkinson’s Disease (PD) include the loss
of dopaminergic neurons in substantia nigra and the presence
of Lewy bodies, which are intracellular inclusions of
aggregated a-Syn. The exact mechanism by which aggregation of a-Syn induces neuronal cell death in the course of the
disease is not yet clear; however, a growing body of evidence
points towards a key role of oxidative stress in PD
pathogenesis (Gandhi and Abramov 2012).
Reactive oxygen species (ROS) and even mild lipid
peroxidation have been shown to play important roles in
physiological signal transduction (Vaarmann et al. 2010;
Domijan et al. 2014), but overproduction of ROS may lead to
oxidative damage to DNA, proteins and/or to lipid membranes.
The extent of tissue damage through oxidation depends on the
tissue composition and on the ability of the intracellular
antioxidant system to restore ROS production to basal levels.
The brain is particularly prone to oxidative damage, due to the
high level of oxidation-prone polyunsaturated fatty acids
(PUFAs), high rates of ROS production due to high oxygen
consumption and energy turnover and low levels of
endogenous antioxidants (Halliwell 2006). Twenty per cent

of all energy generated by the body is utilized by the brain, of
which a striking 25% (i.e. the 5% of the total energy generated)
is spent on maintaining and repairing oxidatively damaged
lipid membranes (Brenna and Carlson 2014).
We have previously shown (Cremades et al. 2012) that
exposure of neurons and astrocytes from a mixed primary
culture to oligomeric forms of a-Syn leads to a dramatic
increase in the basal ROS production.
In this study, we investigate how a-Syn-induced ROS
production may contribute to cell death by generating lipid
peroxidation. We applied low concentrations of recombinant
monomeric or oligomeric a-Syn to primary co-cultures and
measured ROS production as well as lipid peroxidation.
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Alpha-synuclein induces lipid peroxidation

Furthermore, we modulated the lipid peroxidation using
exogenously applied PUFAs in order to ascertain the
relevance of lipid peroxidation on cell toxicity.
CNS tissues are rich in polyunsaturated fatty acids (PUFA)
(Alessandri et al. 2004) which can be built enzymatically from
two essential PUFAs, linoleic acid (C18:2,n-6) and a-linolenic
acid (C18:3,n-3) (Brenner 1974). PUFAs are highly prone to a
non-enzymatic chain reaction of autoxidation (Yin et al.
2011). Initiated by ROS, this process can damage multiple
PUFA residues within lipid membranes. The success of
antioxidant approaches to mitigate Parkinsonism and inhibit
associated lipid peroxidation has been limited (Halliwell
2011). An alternative method (Shchepinov 2007) employs
deuteration at the bis-allylic sites (Scheme 1) to slow down the
rate-limiting step of hydrogen abstraction, resulting in strong
inhibition of the chain reaction of lipid peroxidation (Hill et al.
2012). It has been successfully tested in several lipid peroxidation-related neurological disease models including PD
(Shchepinov et al. 2011) and Friedreich’s ataxia (Cotticelli
et al. 2013). Here, we employ lipid peroxidation- resistant DPUFAs to obtain further mechanistic insights into a-Syn
pathophysiology and ways to prevent it.

Materials and methods
Materials
Deuteration of PUFAs
Deuterated Poly-Unsaturated Fatty Acids (D-PUFAs) 11, 11-D2linoleic acid and 11,11,14,14-D4-a-linolenic acid were prepared as
described previously (Hill et al. 2011) and used as free acids.
Non-deuterated PUFAs were obtained from Sigma–Aldrich (99%;
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St. Louis, MO, USA). Cells were pre-incubated with 10 lM H- or
D-PUFA in the culturing media for 24 h prior to experiment and
washed with HBSS before experiments.
Aggregation of monomeric a-Syn
Generation and characterization of monomeric and oligomeric
a-synuclein. The A90C mutant variant of a-Syn was puriﬁed as a
monomeric fraction from Escherichia coli and labeled with either
maleimide-modiﬁed Alexa Fluor 488 (AF 488), Alexa Fluor 594
(AF 594) or Alexa Fluor 647 (AF647) dyes (Invitrogen, Carlsbad,
CA, USA) via the cysteine thiol moiety. We utilized the method
described in Cremades et al. 2012; to aggregate ﬂuorescently
labeled a-Syn monomers 50% labeled with AF488 [ﬂuorescence
resonance energy transfer (FRET) donor], and 50% with AF647 or
AF594 (FRET acceptors). For the aggregation reactions, equimolecular concentrations of the AF488- and AF647-labeled A90C aSyn in Tris 25 mM (pH 7.4) and 0.1 M NaCl (with 0.01% NaN3 to
prevent bacterial growth during the experiments) were mixed to give
a ﬁnal volume of 300 lL, bringing the total protein concentration to
1 mg/mL (70 lM). The solutions were incubated in the dark at
37°C, with constant agitation at 200 rpm for 4–8 days, during
which time aliquots were taken. At each time point, a 2 lL aliquot
was diluted 105-fold by serial dilution with 0.022 lm-ﬁltered buffer
(Tris 25 mM [pH 7.4] and 0.1 M NaCl) for smFRET analysis at
25°C. As oligomers form, they are statistically likely to contain both
a donor and acceptor label, and FRET is able to occur between
these, allowing them to be separated from the vast majority of
monomeric protein making up the sample. For this study we stopped
the aggregation at 29 h, and single-molecule confocal FRET
analysis conﬁrms the presence of ~ 0.8% oligomers (number of
detected oligomers as a fraction of total number of detected events),
82% of which exhibit a higher FRET efﬁciency characteristic of the
compact, beta-sheet oligomers previously identiﬁed (Cremades
et al. 2012), the other 18% having a lower FRET efﬁciency.

(a)

(b)

(c)

Scheme 1 (a) Chain reaction of lipid peroxidation is initiated by a reactive oxygen species (ROS)-mediated hydrogen abstraction from a bis-allylic
site within a polyunsaturated fatty acids (PUFA). The carbon-based radical thus formed reacts with O2 to yield an alkylperoxy radical, which
abstracts hydrogen from a neighbouring PUFA in the membrane. This propagation of the chain process can be terminated by antioxidants or radical
recombination. The chain process generates a large variety of toxic moieties including peroxides and carbonyls. (b) The essential PUFAs, n-6 Lin
and n-3 Lnn, from which higher essential PUFAs can be built in vivo by enzymatic desaturation and extension. (c) Deuteration at the bis-allylic sites
protects D2-Lin and D4-Lnn from the rate-limiting step of lipid peroxidation.
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Methods

system. To assess lipid peroxidation, C11-BODIPY (581/591,
2 lM, Molecular Probes) was excited using the 488 and 565 nm
laser and ﬂuorescence measured from 505 to 550 nm and above
580 nm (409 objective). For measurements, BODIPY 655/675
(2 lM, Molecular Probes) was excited by 563 and 630 nm lasers
and measured from 580 to 610 and above 650 nm (409 objective).
DAF-FM was measured using excitation 488 nm and emission 510–
560 nm. Illumination intensity was kept to a minimum (at 0.1–0.2%
of laser output) to avoid phototoxicity and the pinhole set to give an
optical slice of ~ 2 lm. Addition of a bright ﬁeld image allowed
separation between neurons and glia, that are visibly different and
are situated on different focal planes. Data were acquired and
analysed using ZEN2009 software.

Primary cultures
Mixed cultures of cortical neurons were prepared as described
previously (Suwanjang et al. 2013) with modiﬁcations, from male
and female Sprague–Dawley rat pups 2–4 days post-partum (UCL
breeding colony). Experimental procedures were performed in full
compliance with the United Kingdom Animal (Scientiﬁc Procedures) Act of 1986.
Rat brains were quickly removed and macerated in chilled Ca2+free HBSS (Invitrogen). The tissue was minced and trypsinized
(0.1% for 15 min at 37°C), triturated and plated on poly-D-lysinecoated coverslips and cultured in Neurobasal A medium
(Gibco-Invitrogen, Paisley, UK) supplemented with B-27 (GibcoInvitrogen), 2 mM L-glutamine and 1% Penicillin/Streptomycin.
Cultures were maintained at 37°C in a humidiﬁed atmosphere of 5%
CO2 and 95% air, media changed twice a week. Neurons were easily
distinguishable from glia: they appeared phase bright, had small
smooth rounded somata and distinct processes, and lay just above
the focal plane of the glial layer.

Toxicity experiments
For toxicity assays cells were exposed to 5 lM propidium iodide
(PI) and 5 lM Hoechst 33342 (Molecular Probes, Eugene, OR) for
30 min prior to imaging. The PI is excluded from viable cells and
exhibits a red ﬂuorescence following a loss of membrane integrity,
while the Hoechst 33342 labels all nuclei blue. This allows
expression of the number of dead (red stained) cells as a fraction
of the total number of nuclei counted (blue stain). Using phase
contrast optics, a bright ﬁeld image allowed identiﬁcation of
neurons, which look quite different to the ﬂatter glial cells and also
lie in a different focal plane, above the glial layer. A total number
of 100–300 neurons were counted in 4–5 ﬁelds of each coverslip.
Each experiment was repeated four or more times using separate
cultures.

Imaging of superoxide generation and lipid peroxidation
Superoxide generation was measured with Dihydroethidium (HEt;
2 lM, Invitrogen). Culturing media was washed off with HBSS and
all imaging was performed in HBSS (Gibco). To avoid accumulation of oxidized products, HEt was not preloaded to the cells, but
was added to the solutions in the beginning of the experiments in
primary co-cultures. Phototoxicity and photobleaching of cells were
minimized by limiting the light exposure to the time of acquisition
of the images. Fluorescent images were acquired with a frame
interval of 10s. Data were analysed using software from Andor IQ
(Belfast, UK).
The rate of lipid peroxidation was measured using confocal
microscopy. Confocal images were obtained with a Zeiss 710 Laser
Scanning Microscope (LSM) with an integrated Meta detection
(b)
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Statistical and data analysis
Statistical analysis and data analysis were performed using Origin
9 (Microcal Software Inc., Northampton, MA, USA) software.
Results are expressed as means  standard error of the mean
(SEM).

p<0.0001
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0
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Fig. 1 The ability of a-synuclein to induce
reactive oxygen species (ROS) is
dependent on the form of its conformation.
ROS production is signiﬁcantly higher when
primary glio-neuronal co-culture was treated
with aggregated (oligomeric) form of alphasynuclein, compared to those treated with
non-aggregated (monomeric) form of alphasynuclein (a and b). (a) shows
representative traces of dihydroethidium
(HEt)
measurements
whereas
(b)
summarizes the effects of the two forms of
alpha-synuclein on the ROS production in
percentage. ns: not signiﬁcant. C – effect
of pre-incubation (20 min) of neurons
and astrocytes with 100 lM Trolox on
a-synuclein-induced ROS production.
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Fig. 2 Aggregated, but not non-aggregated
form of a-synuclein produces lipid
peroxidation. Equivalent amounts of
aggregated
and
non-aggregated
a-synuclein have been tested for their
ability to evoke lipid peroxidation in mixed
glio-neuronal culture, using the C-11
BODIPY 581/591 lipid peroxidation probe.
The addition of the aggregated form of
a-synuclein
only,
induced
lipid
peroxidation. (a), representative traces
showing the increase in basal rate of lipid
peroxidation only after addition of oligomeric
a-synuclein, (b), summary of the results
given in percentage and (c), effect of
100 lM Trolox on lipid peroxidation under
exposure of aggregated a-synuclein. (d)
Effect of aggregated a-synuclein on DAFFM ﬂuorescence.
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Results
The ability of alpha-synuclein to produce ROS depends on
the state of aggregation
In agreement with our previous publication (Cremades et al.
2012) we have found that in rat cortical primary co-cultures of
neurons and astrocytes, application of 100 nM aggregated
a-Syn (consisting of ~ 99 nM monomeric a-Syn and ~ 1 nM
oligomeric a-Syn) but not non-aggregated (100 nM monomeric) a-Syn signiﬁcantly increased the rate of ROS production (Fig. 1a), measured as the rate of increase in HEt ratio
(494.6  17.6%, n = 9, p < 0.0001; and 126.3  19.5%,
n = 9, p = 0.1962; of basal rate 100%, n = 9; accordingly,
Fig. 1b). Thus, aggregated but not the non-aggregated a-Syn
induces ROS formation, indicating that only the aggregated
form exerts a substantial inﬂuence on the cellular ROS
production.
This a-Syn-induced ROS production can be signiﬁcantly
reduced by pre-incubation of the cells (for 20 min) with
water soluble analogue of vitamin E – trolox (100 lM;
Fig. 1c; n = 8 experiments).
Lipid peroxidation is a part of the alpha-synuclein-induced
damage to neurons
Normally, production of ROS can be quenched by an
effective antioxidant system which maintains redox balance.
However, in certain conditions ROS overproduction takes
place, which cannot be balanced by the cellular antioxidant
system and this leads to oxidative stress. Application of
100 nM aggregated a-Syn (equivalent of 99 nM monomeric
and 1 nM oligomeric a-Syn) signiﬁcantly increases the rate
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of lipid peroxidation in primary cultures from the cortex
(679.5  60.9% of basal rate, n = 125; p < 0.001 Fig. 2a
and b), measured as the rate of C11-BODIPY 581/591 ratio.
The effect of monomeric 100 nM a-Syn was indistinguishable from the basal rate (123.17  22.1% of basal rate;
n = 132 cells; Fig. 2a and b). a-Syn penetrates the cells in
5–8 min (Cremades et al. 2012) that suggests that this
peptide can induce lipid peroxidation in all – plasmalemmal
and intracellular membranes. Lipid peroxidation was more
likely to be induced by a-Syn-stimulated ROS production
because pre-incubation with 100 lM Trolox, can also
completely block a-synuclein-induced increase in C11BODIPY 581/591 ratio (Fig. 2c). To avoid any possible
interaction of C11-BODIPY 581/591 ratio with peroxynitrite,
we measured the effect of aggregated a-Syn on NO
production in the co-culture of neurons and astrocytes.
Using DAF-FM as an indicator for NO, we have found that
aggregated a-Syn has no effect on NO production at
the same time with the activation of lipid peroxidation
(Fig. 2d).
To test if D-PUFAs can block a-Syn-induced lipid
peroxidation we treated cortical neurons and astrocytes with
D-PUFA (both D4-Lnn and D2-Lin) and normal H-PUFA
controls (Lnn and Lin acids). We have found that even
control PUFAs reduced the effect of oligomeric a-Syn on
lipid peroxidation, perhaps due to substituting higher, more
oxidation-prone PUFAs present in membranes. Thus, in the
presence of PUFAs, the a-Syn-mediated increase in the rate
of C11-BODIPY 581/591 ratio in neurons and astrocytes
from co-cultures was only 188.3  11.5%, compared to
679.5  60.9% when D-PUFAs were absent, n = 9,
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Isotope-reinforced PUFAs protect against alpha-synucleininduced cell death
In our experiments, 6-h exposure of cortical co-culture of
neurons and astrocytes to 100 nM aggregated a-Syn
(99 nM monomeric a-Syn, 1 nM oligomeric a-Syn) results
in a signiﬁcant increase in the number of dead cells (to
41.7  7.8%, n = 9 experiments, Fig. 5a and b). To
investigate if D-PUFAs have a protective effect on the
survival of neurons and astrocytes upon prolonged exposure
to aggregated a-Syn, we assessed the number of Hoechst/PIpositive cells in a classical cell death assay. About 24-h preincubation of the cells with either an n-6 (D2-Lin) or an n-3
(D4-Lnn) PUFA signiﬁcantly protects the cells against aSyn-induced cell death (17.5  5.2%, n = 9, p = 0.0204
and 21.3  4.3%, n = 9, p = 0.0353, when compared to
cell death evoked by aggregated a-Syn alone –
41.7  7.8%, n = 9; Fig. 5b). These experiments strongly
suggest that lipid peroxidation is an important part of the
mechanism of a-Syn -induced neuronal cell death that
occurs in Parkinson’s disease, and that this effect can be
mitigated by D-PUFAs.

Discussion
It has been previously demonstrated that a-Syn aggregates to
generate a toxic beta-sheet oligomeric structure that generates
high levels of ROS (Cremades et al. 2012). While it is
recognized that overproduction of ROS results in oxidation
of a range of molecules including DNA, protein and lipids
(Gandhi and Abramov 2012), our study provides deﬁnitive
evidence for the induction of lipid peroxidation by oligomeric a-Syn. Importantly, we are also able to demonstrate
that the application of D-PUFAs prevents a-Syn-induced
lipid peroxidation as well as a-Syn-induced cell death. Since
D-PUFAs possess the unique ability to prevent lipid
peroxidation, with no other non-speciﬁc free radical
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Fig. 3a). A total of 24-h pre-incubation of the cells with
D-PUFAs signiﬁcantly reduced the rate of the lipid peroxidation in mixed primary cultures treated with 100 nM
aggregated a-Syn to basal (to 104.7  16.5% from basal
rate, n = 9 experiments, p = 0.0005; Fig. 3b). We have
found no differences in the effects of D4-Lnn and D2-Lin on
the rate of lipid peroxidation (Fig. 3a and c). It should be
noted that the effect of a-Syn was independent of the cell
type when comparing with astrocytes (209.1  19.2%,
n = 9 experiments) and neurons (188.3  11.5%, n = 9
experiments; Fig. 4a and b). The data, obtained using C11BODIPY 581/591 were conﬁrmed by another indicator for
lipid peroxidation BODIPY 655/675 (Fig. 4c). Thus, oligomeric but not monomeric a-Syn induces a signiﬁcant
increase in lipid peroxidation which can be blocked partially
by pre-treatment of the cells with H-PUFAs and completely
by pre-treatment of the cells with D-PUFAs.
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Fig. 3 a-synuclein-induced lipid peroxidation could be prevented by
deuterated polyunsaturated fatty acids (PUFAs). No changes in the
basal rate of lipid peroxidation (representative traces) are evoked by
aggregated a-synuclein in D4-Lnn (a and c) and D2-Lin (b and c) – pretreated co-cultures from rat neurons and astrocytes in C-11 Bodipy
assay in comparison to the non-deuterated forms of PUFA (H-Lin and
H-Lnn). (c), Histogram summarizing changes in the rate of lipid
peroxidation (in percentage) in the presence of deuterated PUFAs.
***p < 0.0001; n.s. non-signiﬁcant.

scavenging or antioxidant properties, this conﬁrms that lipid
peroxidation induced by a-Syn is indeed the major mechanism of toxicity of cells exposed to oligomers.
There is a homology between segments of a-Syn and
fatty acid-binding proteins, suggesting that a-Syn can
function as a lipid-binding protein (Perrin et al. 2001).
Interaction of a-Syn with PUFAs, particularly with
neuron-speciﬁc higher PUFAs such as docosahexanoic
acid, affects its oligomerization and further aggregation
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Fig. 4 Deuterated polyunsaturated fatty acids (PUFAs) prevent
a-synuclein-induced rise in lipid peroxidation in both, cortical neurons
and cortical astrocytes. Aggregated form of a-Syn stimulates lipid
peroxidation in both neurons (a1, a2) and astrocytes (b1, b2), however,

statistically signiﬁcant level of the protective D4-Lnn effect is reached
only in astrocytes (p < 0.0001). c1, c2 – experiments, using alternative
lipid peroxidation indicator BODIPY 655/675.

(De et al. 2011), resulting in increased cytotoxicity. a-Syn
aggregates interact with vesicular transport, and can
embed themselves into lipid membranes forming pores,
and affecting membrane permeability (Fecchio et al. 2013).
Also, a-Syn can bind to membranes, fatty acids and intracellular lipid droplets as reviewed in Ruiperez et al. 2010;. But
rather than a fatty acid carrier, it is the binding to membranes
that seems to be the intrinsic property of a-Syn (Lucke et al.
2006). Interestingly, a-Syn oligomers are formed upon
interaction with peroxidation-prone PUFAs but not with
monounsaturated fatty acids, while non-saturated fatty acids
actually reduce the level of oligomerization (Sharon et al.
2003). Given this and the fact that binding of lipid peroxidation-promoting transition metals such as iron or copper
exacerbates oligomerization of a-Syn (Amer et al. 2006), we

suggest that a-Syn may also have a speciﬁc afﬁnity for
peroxidized lipids. Thus, monomeric a-Syn may increase
resistance to apoptosis, while a-Syn oligomers have the
opposite effect (Ruiperez et al. 2010). While lipid peroxidation features prominently in both apoptosis and a-Synassociated pathology, the detailed pro- and anti-apoptotic
properties of a-Syn and its oligomeric forms, as well as their
complex interactions with PUFAs in mitochondria await
further elucidation (Ruiperez et al. 2010).
Mitochondrial lipid peroxidation has been linked to PD
(Dexter et al. 1986) and apoptosis, which itself may be
linked to several lipid peroxidation events through different
possible pathways, including a recently described ‘lipid
whiskers’ mechanism (Greenberg et al. 2008). Cytochrome c
has to be released into the cytosol from the inner mitochon-
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drial membrane to trigger apoptotic caspase cascades. For
this to happen, cardiolipin, a major PUFA-rich building
block of inner mitochondrial membranes, has to be oxidized
(Kagan et al. 2005). This oxidation can be triggered by
elevation of ROS production in the vicinity of PUFA-rich
mitochondrial membranes. Other apoptosis-initiating steps
may include the loss of membrane potential (Zamzami et al.
1995) as a result of lipid peroxidation-driven change in the
membrane ﬂuidity (Dobretsov et al. 1977). Membranebound peroxidized PUFAs decompose into numerous toxic
moieties. Reactive carbonyls such as 4-hydroxynonenal
(HNE), 4-hydroxy-2-hexenal (HHE), malondialdehyde
(MDA), acrolein and many other can damage proteins, lipids
and nucleic acids and activate the caspase cascades (Ellis
2007). Despite the fact that it was shown that monomers
could bind to fatty acids and form oligomers upon reacting
with products of lipid peroxidation (Broersen et al. 2006), in
our hands only exogenously applied oligomers could
produce ROS, thus inducing lipid peroxidation.
The observed pernicious role of the ROS-induced chain
reaction of lipid peroxidation in the toxicity of aggregated

Fig. 5 Protective effect of deuterated
polyunsaturated fatty acid (PUFA) against
a-synuclein-induced cell death. About
100 nM aggregated (but not nonaggregated) alpha-synuclein signiﬁcantly
increased the number of dead cells in
primary glio-neuronal cultures (a). Preincubation of the cells with deuterated
PUFA-containing medium (either D4-Lnn
or D2-Lin) signiﬁcantly reduced the number
of dead cells (given in percent) in the culture
(a and b). Cell death was assessed using
PI/Hoechst assay to label dead cells and
total number of cells, respectively.

a-Syn suggests that down-regulating lipid peroxidation may
have a mitigating effect on PD progression. However,
attempts to use antioxidants to inhibit the ROS-inﬂicted
damage in lipid peroxidation and elsewhere have so far been
unsuccessful (Halliwell 2011). This may be due to a variety
of factors, including (a) near-saturating levels of antioxidants
present normally, (b) preventing important signalling function played by ROS, (c) antioxidants switching to prooxidant mode under certain conditions, (d) challenges of
delivering the antioxidants to the particular cellular locations
where they are most required and (e) the need to constantly
supply antioxidants as they are used up in the process of ROS
quenching. An alternative strategy, that of making PUFAs
more resistant to lipid peroxidation through site-speciﬁc
deuteration, is free of these drawbacks. Hydrogen abstraction
off a bis-allylic site, the rate-limiting step of the process, can
be slowed down by deuteration due to the kinetic isotope
effect. The kinetic isotope effect is further multiplied through
the chain format, essentially resulting in the inhibition of
lipid peroxidation, with stochiometric (non-chain) enzymatic
reactions of lipid oxidation affected to a much lesser degree.

© 2015 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of
The International Society for Neurochemistry, J. Neurochem. (2015) 133, 582--589
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The essential nature of PUFAs would ensure efﬁcient
delivery of reinforced PUFAs to the sites with elevated lipid
peroxidation, making D-PUFAs a clinically relevant therapeutic approach for mitigating PD.
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